Deferasirox

Product NDC
0480-7013
11-digit product format
004807013
Labeler code
0480
Product ID
0480-7013_41368299-3cb6-4cee-885e-5c1cc8e4fee6
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Deferasirox
Dosage form
TABLET, FOR SUSPENSION
Route
ORAL
Labeler
Teva Pharmaceuticals, Inc.
Application
ANDA207124
Marketing category
ANDA
Marketing start
2024-11-01
Substance
DEFERASIROX
Active strength
500 mg/1
Pharmacologic classes
Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A207124-001DEFERASIROXDEFERASIROX125MGTABLET, FOR SUSPENSION / ORALAB2022-09-23
A207124-002DEFERASIROXDEFERASIROX250MGTABLET, FOR SUSPENSION / ORALAB2022-09-23
A207124-003DEFERASIROXDEFERASIROX500MGTABLET, FOR SUSPENSION / ORALAB2022-09-23

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
A207124-001AB
A207124-002AB
A207124-003AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 78 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A207124-001DEFERASIROX125MGTABLET, FOR SUSPENSION / ORALAB2022-09-23011fe1cb6892…
2026-02-19 14:30 UTC2026-02A207124-002DEFERASIROX250MGTABLET, FOR SUSPENSION / ORALAB2022-09-23011fe1cb6892…
2026-02-19 14:30 UTC2026-02A207124-003DEFERASIROX500MGTABLET, FOR SUSPENSION / ORALAB2022-09-23011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A207124-001DEFERASIROX125MGTABLET, FOR SUSPENSION / ORALAB2022-09-2331067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A207124-002DEFERASIROX250MGTABLET, FOR SUSPENSION / ORALAB2022-09-2331067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A207124-003DEFERASIROX500MGTABLET, FOR SUSPENSION / ORALAB2022-09-2331067a03dcf5…
2025-08-23 18:47 UTC2025-08A207124-001DEFERASIROX125MGTABLET, FOR SUSPENSION / ORALAB2022-09-236a471c1ec25d…
2025-08-23 18:47 UTC2025-08A207124-002DEFERASIROX250MGTABLET, FOR SUSPENSION / ORALAB2022-09-236a471c1ec25d…
2025-08-23 18:47 UTC2025-08A207124-003DEFERASIROX500MGTABLET, FOR SUSPENSION / ORALAB2022-09-236a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A207124-001DEFERASIROX125MGTABLET, FOR SUSPENSION / ORALAB2022-09-23fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A207124-002DEFERASIROX250MGTABLET, FOR SUSPENSION / ORALAB2022-09-23fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A207124-003DEFERASIROX500MGTABLET, FOR SUSPENSION / ORALAB2022-09-23fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A207124-001DEFERASIROX125MGTABLET, FOR SUSPENSION / ORALAB2022-09-23b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A207124-002DEFERASIROX250MGTABLET, FOR SUSPENSION / ORALAB2022-09-23b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A207124-003DEFERASIROX500MGTABLET, FOR SUSPENSION / ORALAB2022-09-23b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A207124-001DEFERASIROX125MGTABLET, FOR SUSPENSION / ORALAB2022-09-2303ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A207124-002DEFERASIROX250MGTABLET, FOR SUSPENSION / ORALAB2022-09-2303ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A207124-003DEFERASIROX500MGTABLET, FOR SUSPENSION / ORALAB2022-09-2303ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A207124-001DEFERASIROX125MGTABLET, FOR SUSPENSION / ORALAB2022-09-232680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A207124-002DEFERASIROX250MGTABLET, FOR SUSPENSION / ORALAB2022-09-232680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A207124-003DEFERASIROX500MGTABLET, FOR SUSPENSION / ORALAB2022-09-232680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A207124-001DEFERASIROX125MGTABLET, FOR SUSPENSION / ORALAB2022-09-235bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A207124-002DEFERASIROX250MGTABLET, FOR SUSPENSION / ORALAB2022-09-235bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A207124-003DEFERASIROX500MGTABLET, FOR SUSPENSION / ORALAB2022-09-235bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A207124-001DEFERASIROX125MGTABLET, FOR SUSPENSION / ORALAB2022-09-23d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A207124-002DEFERASIROX250MGTABLET, FOR SUSPENSION / ORALAB2022-09-23d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A207124-003DEFERASIROX500MGTABLET, FOR SUSPENSION / ORALAB2022-09-23d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A207124-001DEFERASIROX125MGTABLET, FOR SUSPENSION / ORALAB2022-09-23d06236e962d9…
2024-10-29 15:01 UTC2024-10A207124-002DEFERASIROX250MGTABLET, FOR SUSPENSION / ORALAB2022-09-23d06236e962d9…
2024-10-29 15:01 UTC2024-10A207124-003DEFERASIROX500MGTABLET, FOR SUSPENSION / ORALAB2022-09-23d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A207124-001DEFERASIROX125MGTABLET, FOR SUSPENSION / ORALAB2022-09-2379d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A207124-002DEFERASIROX250MGTABLET, FOR SUSPENSION / ORALAB2022-09-2379d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A207124-003DEFERASIROX500MGTABLET, FOR SUSPENSION / ORALAB2022-09-2379d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A207124-001DEFERASIROX125MGTABLET, FOR SUSPENSION / ORAL2022-09-23301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A207124-002DEFERASIROX250MGTABLET, FOR SUSPENSION / ORAL2022-09-23301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A207124-003DEFERASIROX500MGTABLET, FOR SUSPENSION / ORAL2022-09-23301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A207124-001DEFERASIROX125MGTABLET, FOR SUSPENSION / ORAL2022-09-231e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A207124-002DEFERASIROX250MGTABLET, FOR SUSPENSION / ORAL2022-09-231e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A207124-003DEFERASIROX500MGTABLET, FOR SUSPENSION / ORAL2022-09-231e350fbaab3a…
2024-05-31 18:47 UTC2024-05A207124-001DEFERASIROX125MGTABLET, FOR SUSPENSION / ORAL2022-09-238072bd15b7f6…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 45 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02A207124-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A207124-002AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A207124-003AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A207124-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A207124-002AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A207124-003AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A207124-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A207124-002AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A207124-003AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A207124-001AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A207124-002AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A207124-003AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A207124-001AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A207124-002AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A207124-003AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A207124-001AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A207124-002AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A207124-003AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A207124-001AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A207124-002AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A207124-003AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A207124-001AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A207124-002AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A207124-003AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A207124-001AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A207124-002AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A207124-003AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A207124-001AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10A207124-002AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10A207124-003AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A207124-001AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A207124-002AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A207124-003AB179d66fd596c7…
2023-01-26 05:58 UTC2023-01A207124-001AB13bdfa0b2c4d7…
2023-01-26 05:58 UTC2023-01A207124-002AB13bdfa0b2c4d7…
2023-01-26 05:58 UTC2023-01A207124-003AB13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A207124-001AB13a93d1ddd44b…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A207124-002AB13a93d1ddd44b…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A207124-003AB13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A207124-001AB1f41ea6bd6efb…

Additional Listing Data#

Finished product
Yes
Brand name base
Deferasirox
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
DEFERASIROX500 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
V8G4MOF2V9Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
597768Internal RxNorm lookup
597770Internal RxNorm lookup
597772Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
e9054806-2721-4736-9aef-81ffb8db75d1Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
1e1ec29c-8ce7-9963-3c87-cf7d9cd3b139Product name520250624
0feb0248-301d-406d-9b41-7d80ddbec8a8Product name420201216

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0480-7013-56Deferasirox30 in 1 BOTTLETABLET, FOR SUSPENSION307

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0480-7013-56EA - Each0480-7013514a9cb6-3627-4c68-94b5-77e20783d42d12024-12-10

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0480-7013DEFERASIROX TABLET, FOR SUSPENSION [TEVA PHARMACEUTICALS, INC.]6Current NDC, 1 package rows20241210_e9054806-2721-4736-9aef-81ffb8db75d1.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DeferasiroxDEFERASIROXTeva Pharmaceuticals, Inc.e9054806-2721-4736-9aef-81ffb8db75d12024-07-01Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 207124
application number: ANDA207124
ndc (product): 0480-7013

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
597768deferasirox 125 MG Tablet for Oral SuspensionPSNe9054806-2721-4736-9aef-81ffb8db75d17
597770deferasirox 250 MG Tablet for Oral SuspensionPSNe9054806-2721-4736-9aef-81ffb8db75d17
597772deferasirox 500 MG Tablet for Oral SuspensionPSNe9054806-2721-4736-9aef-81ffb8db75d17
597768deferasirox 125 MG Tablet for Oral SuspensionSCDe9054806-2721-4736-9aef-81ffb8db75d17
597770deferasirox 250 MG Tablet for Oral SuspensionSCDe9054806-2721-4736-9aef-81ffb8db75d17
597772deferasirox 500 MG Tablet for Oral SuspensionSCDe9054806-2721-4736-9aef-81ffb8db75d17

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
0480-7013-560048070135630 TABLET, FOR SUSPENSION in 1 BOTTLE (0480-7013-56) 2024-11-01NoNoCurrent